Skip to Main Content

Paper Details

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
Nat Commun
36
2022
CD8, CTLA-4, CX3CR1, CX3CR1 CD8 T cells, CXCL9/10/11/16, CXCR3, CXCR3 CD8 T cells, PD-1, T cells, TCR repertoires, Th1, Th1-CD8 T cell, Th17, arthritis, blood CX3CR1 CD8 T cells, cancer, immune, inflammatory arthritis, myeloid cells, patients
Author NameAffiliation
Charles LuThe University of Texas MD Anderson Cancer Center
Bora LimThe University of Texas MD Anderson Cancer Center
Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center
Hussein A TawbiThe University of Texas MD Anderson Cancer Center
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Phillip A FutrealThe University of Texas MD Anderson Cancer Center
Linghua WangThe University of Texas MD Anderson Cancer Center
Linghua WangThe University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
  • 1 - 9

Datasets

Release 1.2